ArticleeLife2026
Global risk mapping of highly pathogenic avian influenza H5N1 and H5Nx in the light of epidemic episodes occurring from 2020 onwards.
Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Avian Influenza at the Wild Bird-Poultry Interface: An Asia-Focused Review with Ecological Risk Scenarios for China.Animals : an open access journal from MDPI · 2026Review
- Swine Influenza Virus Introduction in Pig Farms: A Semi-Quantitative Risk Assessment in Northern Italy.Animals : an open access journal from MDPI · 2026Article
- Global dynamics of avian influenza: a twenty-year analysis of highly pathogenic viruses linking the Caspian Basin, Eurasia and Africa sectors (2005-2025).Frontiers in cellular and infection microbiology · 2026Review
- Avian influenza risk mapping in India using machine learning.Frontiers in veterinary science · 2026Article
- Continuous phylogeography reveals shifting environmental drivers of highly pathogenic avian influenza H5 spread in Italy, 2016-23.Virus evolution · 2026Article
- Microbiome-Immune Interaction and Harnessing for Next-Generation Vaccines Against Highly Pathogenic Avian Influenza in Poultry.Vaccines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Avian influenza (AI) is a highly contagious viral disease affecting poultry and wild water birds, posing significant global challenges due to its high mortality rates and economic impacts. Highly pathogenic avian influenza (HPAI) outbreaks, particularly those caused by H5N1 and its variants, have surged since 1959. The HPAI H5N1 clade 2.3.4.4b viruses have notably expanded their geographical reach, affecting numerous countries, diverse avian species, and now mammals. Using an ecological niche modelling approach, this study aims to elucidate the environmental factors associated with increased HPAI H5 cases since 2020, investigate potential shifts in ecological niches, and predict new areas suitable for viral circulation. We developed ecological niche models for HPAI cases in wild and domestic birds across two distinct periods: 2015-2020 and 2020-2022. Key environmental predictors include chicken and duck population density, human density, distance to water bodies, and land cover variables. Post-2020, we observe increased relative influence of predictors such as intensive chicken population density and cultivated vegetation. Risk maps reveal notable ecological suitability for HPAI H5 circulation in Europe, Asia, and the Americas, with significant expansions of at-risk areas post-2020. Wild bird H5 occurrences appear primarily correlated with urban areas and open water regions. Our analyses also highlight a potential shift in affected wild bird species diversity, with more avian species, particularly sea birds, impacted post-2020. Overall, these results further contribute to the understanding of HPAI epidemiology and identify regions where surveillance and control measures should be prioritised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.